DXC Technology Full Year 2025 Earnings: EPS Beats Expectations

DXC Technology (NYSE:DXC) Full Year 2025 Results

Key Financial Results

• Revenue: US$12.9b (down 5.8% from FY 2024).
• Net income: US$389.0m (up 328% from FY 2024).
• Profit margin: 3.0% (up from 0.7% in FY 2024).
• EPS: US$2.15 (up from US$0.47 in FY 2024).

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

All figures shown in the chart above are for the trailing 12 month (TTM) period

DXC Technology EPS Beats Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 162%.

The primary driver behind last 12 months revenue was the Global Business Services (GBS) segment contributing a total revenue of US$6.65b (52% of total revenue). Notably, cost of sales worth US$9.77b amounted to 76% of total revenue thereby underscoring the impact on earnings. The largest operating expense was Depreciation & Amortisation (D&A) costs, amounting to US$1.29b (47% of total expenses). Explore how DXC's revenue and expenses shape its earnings.

Looking ahead, revenue is expected to decline by 3.9% p.a. on average during the next 3 years, while revenues in the IT industry in the US are expected to grow by 10%.

Performance of the American IT industry.

The company's shares are up 1.0% from a week ago.

Risk Analysis

We should say that we've discovered 3 warning signs for DXC Technology (1 is potentially serious!) that you should be aware of before investing here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.